Anifrolumab Asian PhIII efficacy study for Systemic Lupus Erythematosus (SLE)

Trial Identifier: D3468C00003
Sponsor: AstraZeneca
NCTID:: NCT04931563
Start Date: September 2021
Primary Completion Date: January 2025
Study Completion Date: March 2025
Condition: Lupus

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
CN baoding, CN, 071000
CN Baotou, CN, 014010
CN Beijing, CN, 100144
CN Beijing, CN, 100191
CN Beijing, CN, 100730
CN Beijing, CN, 100034
CN Changchun, CN
CN Changchun, CN, 130033
CN Changsha, CN, 430033
CN Changsha, CN, 410008
CN changzhi, CN, 46000
CN Chongqing, CN, 400038
CN Chuangchun, CN, 130012
CN Guangzhou, CN, 510080
CN Guangzhou, CN, 510260
CN Guilin, CN, 541001
CN Hangzhou, CN, 310006
CN Jieyang, CN, 522000
CN Jinan, CN, 250012
CN JINING, CN, 272011
CN Kunming, CN, 650032
CN luoyang, CN, 471003
CN Nan Chong, CN, 637000
CN Nanchang, CN, 330006
CN Nanjing, CN, 210008
CN Shanghai, CN, 200025
CN Shengyang, CN, 110004
CN Shenyang, CN, 110001
CN Shenzhen, CN, 518020
CN suzhou, CN, 215006
CN Tianjin, CN, 300052
CN Urumqi, CN, 831118
CN Wenzhou, CN, 325000
CN Wuhan, CN, 430022
CN Wuhan, CN, 430030
CN Wuxi, CN, 214002
CN Xiamen, CN, 361003
CN Xi'an, CN, 710061
CN Zhengzhou, CN, 450052
HK Hong Kong, HK
HK Hong Kong, HK, 00000
HK Shatin, HK, 00000
KR Gwangju, KR, 501-757
KR Jung-gu, KR, 41944
KR Seoul, KR, 6591
KR Seoul, KR, 143-729
KR Seoul, KR, 03080
KR Seoul, KR, 04763
KR Suwon-si, KR, 16499
PH Davao, PH, 8000
PH Davao City, PH, PH-8000
PH Iloilo City, PH, 5000
PH Lipa City, PH, 4217
PH Manila, PH, 1000
PH Quezon City, PH, 1112
TH Bangkok, TH, 10400
TH Bangkok, TH, 10700
TH Hat Yai, TH, 90110
TH Muang, TH, 50200
TW Kaohsiung, TW, 833
TW Kaohsiung, TW, 81362
TW New Taipei, TW, 220
TW Taichung, TW, 40447
TW Taichung, TW, 40705
TW Taichung City, TW, 402
TW Taipei, TW, 100
TW Taipei, TW, 23561
TW Taipei, TW, 112
TW Taipei, TW, 11220
TW Taipei City, TW, 114
TW Tao-Yuan, TW, 333